BFS
KALA icon

Bradley Foster & Sargent’s KALA BIO KALA Stock Holding History

Bradley Foster & Sargent’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9
Closed -$90K – 363
2019
Q3 		$90K Hold
9
– – ﹤0.01% 340
2019
Q2 		$151K Hold
9
– – 0.01% 342
2019
Q1 		$195K Hold
9
– – 0.01% 340
2018
Q4 		$115K Buy
+9
New +$156K ﹤0.01% 333

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bradley Foster & Sargent's KALA Position: Q4 2019 in Review

Bradley Foster & Sargent sold out of KALA BIO (KALA) in Q4 2019, closing a stake of 9 shares — an estimated $90K sold.

Bradley Foster & Sargent first reported a position in KALA in Q4 2018 and held it in 4 quarters. The position peaked at $195K in Q1 2019. 63 funds tracked by Wall St. Rank hold KALA as of Q4 2019.

  • Bradley Foster & Sargent reported no remaining KALA BIO position as of Q4 2019 after selling out during the quarter.
  • Bradley Foster & Sargent sold 9 KALA BIO shares in Q4 2019, an estimated $90K.
  • Bradley Foster & Sargent first reported a position in KALA BIO in Q4 2018 and held it in 4 quarters.
  • Bradley Foster & Sargent's KALA BIO position peaked at $195K in Q1 2019.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q4 2019.

Based on Bradley Foster & Sargent's 13F filing for Q4 2019, filed 29 Jan 2020.